Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD

NCT06215144 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

95

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

DRUG: NRCT-101SR

Sponsor

Neurocentria, Inc.